Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: VistaGen Therapeutics Inc. VTGN

VistaGen Therapeutics, Inc. (NASDAQ: VTGN) Moves Forward in Developing As-Needed Treatment for Social Anxiety Disorder

Company signs a worldwide licensing agreement with Pherin Pharmaceuticals for the development and commercialization of a Phase 3-ready CNS drug candidate for as-needed treatment of social anxiety disorder Untreated social anxiety disorder has a significant impact on a person’s overall … Continue reading

Posted in VistaGen Therapeutics Inc. VTGN | Leave a comment